The Food and Drug Administration (FDA) has approved updated labeling for Farxiga (dapagliflozin; AstraZeneca) and Xigduo XR (dapagliflozin and metformin HCl extended-release; AstraZeneca) to expand ...
AstraZeneca ( AZN) and Bristol-Myers Squibb Company 's ( BMY) diabetes drug, Xigduo gained approval in the EU. The European Commission approved the drug for improving glycemic control in adults ...
LONDON (Reuters) - AstraZeneca said European regulators had approved Xigduo for type 2 diabetes, in what was the first green light for a fixed dose combination of a SGLT2 inhibitor and metformin. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback